Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency

Phase 3 Completed 168 enrolled Novo Nordisk A/S

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This trial is conducted in Asia. The aim of this trial is to evaluate the new liquid somatropin formulation in children with growth hormone deficiency.

Timeline

Start: 2000-10-23
Primary completion: 2002-10-10
Completion: 2002-10-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Somatropin	Protein / enzyme biologic	—	Subcutaneous

Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency

Summary

Timeline

Drugs

Indications